COR:NYSE
Cencora, Inc.
Data as of 2026-03-10 - not real-time
$361.80
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Cencora, Inc. is trading above its short‑term moving averages, confirming a bullish price trend, while the RSI hovers around the neutral midpoint, suggesting balanced momentum. The MACD has turned bearish, indicating a potential short‑term pullback as the stock approaches a key resistance zone. Recent earnings showed solid top‑line growth and an EPS beat, but margins remain thin and debt levels are high, which tempers optimism. Analysts maintain a buy consensus with price targets well above the current level, yet the discounted cash‑flow model signals a valuation gap that could limit upside.
Overall, the stock presents a mixed picture: strong cash generation and dividend sustainability offset by overvaluation, leverage concerns, and modest profitability. Investors should weigh the near‑term technical weakness against the longer‑term growth narrative and sector stability.
Overall, the stock presents a mixed picture: strong cash generation and dividend sustainability offset by overvaluation, leverage concerns, and modest profitability. Investors should weigh the near‑term technical weakness against the longer‑term growth narrative and sector stability.
Trading Recommendations
Short Term
< 1 yearhold
Conviction: 6/10
Key Factors
- Price near resistance with bearish MACD histogram
- Neutral RSI indicating no strong momentum shift
- Stable volume supporting liquidity
Medium Term
1–3 yearsbuy
Conviction: 7/10
Key Factors
- Analyst price targets above current level
- Revenue growth and EPS beat reinforcing earnings momentum
- Sustainable dividend and strong operating cash flow
Long Term
> 3 yearshold
Conviction: 5/10
Key Factors
- High valuation relative to DCF and industry peers
- Elevated debt-to-equity ratio limiting financial flexibility
- Essential healthcare distribution business providing defensive qualities
Key Metrics & Analysis
Financial Health
Revenue Growth5.50%
Profit Margin0.50%
P/E Ratio43.5
ROE133.47%
ROA3.33%
Debt/Equity472.58
P/B Ratio36.9
Op. Cash Flow$4.3B
Free Cash Flow$3.5B
Industry P/E25.4
Technical Analysis
TrendBullish
RSI50.9
Support$347.03
Resistance$376.92
MA 20$363.26
MA 50$353.98
MA 200$322.67
MACDBearish
VolumeStable
Fear & Greed Index75.89
Valuation
Fair Value$270.07
Target Price$410.00
Upside/Downside13.32%
GradeOvervalued
TypeGrowth
Dividend Yield0.66%
Risk Assessment
Beta0.01
Volatility39.76%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
More Tickers
This analysis may contain inaccuracies. Not financial advice. Always do your own research before making any investment decisions.